In the context of AAA pathophysiology, the aortic wall weakening is driven by ECM remodeling and degradation, leading to stimulation of cell death and inflammation, primarily mediated by Matrix metallopeptidase 12 (MMP‐12) [21]. Here, MMP12 is linked to triple-A syndrome.